Israel-based Treato has appointed Gregory Gallo as its new chief commercial officer.
Working out of the online healthcare consumer insights firm’s Princeton, New Jersey office, Gallo will be responsible for leading its business solutions unit as well as expanding the firm’s global presence in the pharmaceutical industry.
Ido Hadari, Treato’s chief executive officer, said: “Greg has a remarkable track record in helping build, lead and scale innovative businesses.
“We are excited to have Greg join our leadership team and look forward to benefitting from his vast knowledge and commercial experience in the healthcare data and analytics field.”
Gallo has over 20 years of commercial experience in the healthcare and pharmaceutical industries, having held senior roles at IntelliSante, ImpactRX, Johnson & Johnson and Quest Diagnostics.
He joins Treato from Activate Networks, now a part of Decision Resources Group, where he served as chief commercial officer and oversaw its commercial operations and growth.